Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ANEB | Common Stock, par value $0.001 per share | Award | $5M | +714K | +27.16% | $7.00 | 3.34M | May 6, 2021 | 22NW Fund, LP | F1 |
holding | ANEB | Common Stock, par value $0.001 per share | 4.65M | May 6, 2021 | Pharma Investors, LLC |
Id | Content |
---|---|
F1 | This Form 4 is being filed to amend the prior Form 4 filed by the Reporting Persons with the U.S. Securities and Exchange Commission on May 7, 2021. The prior Form 4 is hereby corrected to state that the entity that directly holds the securities is 22NW Fund, LP, not 22NW, LP. In addition, the prior Form 4 is hereby corrected to state that the amount of securities purchased in the transaction on May 6, 2021 is 714,250, not 714,286. Accordingly, the total amount of shares owned by 22NW Fund, LP is 3,343,565. Mr. English, as the Manager of 22NW Fund GP, LLC, which is the General Partner of 22NW Fund, LP, may be deemed to beneficially own the securities owned directly by 22NW Fund, LP. |